The discovery of cardiac natriuretic hormones required a profound revision of the concept of
heart function. The heart should no longer be considered only as a pump but rather as a …

Heart failure is common, yet it is difficult to treat. It presents in many different guises and
circumstances in which therapy needs to be individualized. The Canadian Cardiovascular …

Context It is uncertain whether intensified heart failure therapy guided by N-terminal brain
natriuretic peptide (BNP) is superior to symptom-guided therapy. Objective To compare 18 …

Since brain natriuretic peptide (BNP) has become internationally recognized biomarkers in
the diagnosis and prognosis of heart failure (HF), it is highly desirable to search for a novel …

This study sought to evaluate the potential of circulating long non‐coding RNA s (lnc RNA s)
as biomarkers for heart failure (HF). We measured the circulating levels of 13 individual lnc …

Aims Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are both associated
with increased levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). It is known …

Objectives: To determine whether natriuretic peptide concentrations would predict all cause
mortality in dogs with degenerative mitral valve disease. Methods: One hundred dogs with …

The ion-sensitive field effect transistor (ISFET) has emerged as a pivotal sensor device due
to its remarkable advantages, including label-free operation, miniaturization, high sensitivity …

Brain natriuretic peptide (BNP) modulates several biological processes by activating the
natriuretic peptide receptor A (NPR-A). Atria and ventricles secrete BNP. BNP increases …

Study objectives B-type natriuretic peptide (BNP) and N-terminal pro BNP (NTproBNP) have
been shown to correlate with pulmonary arterial wedge pressure (PAWP) in patients with …